Arrowstreet Capital’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.7M | Sell |
1,697,225
-96,228
| -5% | -$778K | 0.01% | 807 |
|
|
2025
Q1 | $15M | Buy |
1,793,453
+252,395
| +16% | +$2.12M | 0.01% | 683 |
|
|
2024
Q4 | $12.2M | Sell |
1,541,058
-527,921
| -26% | -$4.18M | 0.01% | 764 |
|
|
2024
Q3 | $17.2M | Buy |
2,068,979
+1,269,641
| +159% | +$10.6M | 0.01% | 577 |
|
|
2024
Q2 | $5.08M | Buy |
799,338
+167,430
| +26% | +$1.06M | ﹤0.01% | 836 |
|
|
2024
Q1 | $3.83M | Buy |
631,908
+420,234
| +199% | +$2.55M | ﹤0.01% | 969 |
|
|
2023
Q4 | $1.29M | Sell |
211,674
-590,914
| -74% | -$3.59M | ﹤0.01% | 1057 |
|
|
2023
Q3 | $3.39M | Sell |
802,588
-110,386
| -12% | -$466K | ﹤0.01% | 741 |
|
|
2023
Q2 | $2.83M | Buy |
912,974
+231,957
| +34% | +$719K | ﹤0.01% | 750 |
|
|
2023
Q1 | $947K | Buy |
681,017
+183,543
| +37% | +$255K | ﹤0.01% | 1077 |
|
|
2022
Q4 | $990K | Buy |
+497,474
| New | +$990K | ﹤0.01% | 1029 |
|
|
2022
Q2 | – | Sell |
-349,320
| Closed | -$1.46M | – | 1215 |
|
|
2022
Q1 | $1.46M | Buy |
349,320
+146,754
| +72% | +$612K | ﹤0.01% | 871 |
|
|
2021
Q4 | $970K | Buy |
202,566
+111,276
| +122% | +$533K | ﹤0.01% | 1167 |
|
|
2021
Q3 | $487K | Sell |
91,290
-157,870
| -63% | -$842K | ﹤0.01% | 1422 |
|
|
2021
Q2 | $1.28M | Sell |
249,160
-262,592
| -51% | -$1.34M | ﹤0.01% | 1471 |
|
|
2021
Q1 | $3.44M | Buy |
+511,752
| New | +$3.44M | ﹤0.01% | 1336 |
|
|
2020
Q4 | – | Sell |
-114,213
| Closed | -$443K | – | 2267 |
|
|
2020
Q3 | $443K | Sell |
114,213
-1,174,869
| -91% | -$4.56M | ﹤0.01% | 2050 |
|
|
2020
Q2 | $6.14M | Buy |
1,289,082
+1,089,819
| +547% | +$5.19M | 0.01% | 971 |
|
|
2020
Q1 | $693K | Buy |
199,263
+5,527
| +3% | +$19.2K | ﹤0.01% | 1435 |
|
|
2019
Q4 | $934K | Buy |
+193,736
| New | +$934K | ﹤0.01% | 1353 |
|